Subversion of the chemotherapy-induced anticancer immune response by the ecto-ATPase CD39
Year: 2012
Type: article
Abstract: The efficacy of antineoplastic chemotherapies with anthracyclines or oxaliplatin relies on the induction of immunogenic cell death, thus provoking an anticancer immune response. Recently, we observed that overexpression of CD39, an ATP-degrading enzyme expressed on the cell surface, abolishes the immunogenicity of cell death, thus rendering cancers resistant against chemotherapy.
Source: OncoImmunology
DOI: 10.4161/onci.19070
Language: English
Subfield: Physiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,913
OpenAlex ID: W2146110549
